Thrombosis and haemostasis
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study.
Xavier Delavenne, Jean Escal, Dominique Helley, Laurent Bertoletti, Nicolas Falvo, Isabelle Mahé, Benjamin Crichi, Francis Couturaud, Marie-Antoinette Sevestre, Michel Pavic, Laetitia Mauge, Sara Zia-Chahabi, Aurélie Vilfaillot, Juliette Djadi-Prat, Patrick Mismetti
Published: 202510.1055/a-2740-1841
Abstract
Cancer-associated thrombosis (CAT) is common and a leading cause of mortality in patients with cancer. In specific CAT scenarios, low-molecular-weight heparins (LMWHs), including tinzaparin, are preferred over direct oral anticoagulants. Despite the…
Preview only. Read the full abstract at the source